- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- kirilystherapeutics.com
- Last Round
- SeedJan 2022
- Rounds
- 1
About
Preclinical-stage biopharmaceutical company developing antibody-drug conjugates and CDK7 inhibitors for precision oncology.
Summary
Kirilys Therapeutics is a Biotech company based in United States, founded in 2021. Its most recent funding was a Seed round in Jan 2022. Investors include Lightspeed VP, Global Brain and Mercury Fund.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2022
Investors
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform